The holistic 3M modality of drug delivery nanosystems for cancer therapy (Q38071901)

28 August 2017

1 reference

title

The holistic 3M modality of drug delivery nanosystems for cancer therapy (English)

1 reference

28 August 2017

1 reference

Jin Sun

1

1 reference

28 August 2017

Cong Luo

series ordinal

2

1 reference

28 August 2017

Yongjun Wang

series ordinal

3

1 reference

28 August 2017

Zhonggui He

series ordinal

4

1 reference

28 August 2017

language of work or name

English

0 references

publication date

4 January 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

5

1 reference

28 August 2017

issue

3

1 reference

28 August 2017

page(s)

845-859

1 reference

Hallmarks of Cancer: The Next Generation

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Role of tumor vascular architecture in drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Targeted drug delivery to tumors: myths, reality and possibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Paclitaxel tumor-priming enhances siRNA delivery and transfection in 3-dimensional tumor cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Biodistribution and pharmacokinetic analysis of Paclitaxel and ceramide administered in multifunctional polymer-blend nanoparticles in drug resistant breast cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Exploiting the enhanced permeability and retention effect for tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Cancer. The metastasis cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Multifunctional nanocarriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Multistage nanoparticles for improved delivery into tumor tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Adaptive micro and nanoparticles: temporal control over carrier properties to facilitate drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Spatiotemporal controlled delivery of nanoparticles to injured vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

SARS-Associated Coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Non-invasive assessment of tumor neovasculature: techniques and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Lactoferrin-conjugated superparamagnetic iron oxide nanoparticles as a specific MRI contrast agent for detection of brain glioma in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Targeting of nanoparticles in cancer: drug delivery and diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Targeting therapy with mitosomal daunorubicin plus amlodipine has the potential to circumvent intrinsic resistant breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Mitochondria-targeted peptide antioxidants: novel neuroprotective agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Cell-permeable, mitochondrial-targeted, peptide antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Drugs, their targets and the nature and number of drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Randomized crossover pharmacokinetic study of solvent-based paclitaxel and nab-paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Comparative preclinical and clinical pharmacokinetics of a cremophor-free, nanoparticle albumin-bound paclitaxel (ABI-007) and paclitaxel formulated in Cremophor (Taxol).

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Nanoparticle therapeutics: an emerging treatment modality for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Targeted drug delivery in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: preparation, characterization and efficacy in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Choline-derivate-modified nanoparticles for brain-targeting gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Ligands for mapping alphavbeta3-integrin expression in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

APN/CD13-targeting as a strategy to alter the tumor accumulation of liposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Improving penetration in tumors with nanoassemblies of phospholipids and doxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Synergistic antitumor activity of metronomic dosing of cyclophosphamide in combination with doxorubicin-containing PEGylated liposomes in a murine solid tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Improving delivery and efficacy of nanomedicines in solid tumors: role of tumor priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Nanoparticle-mediated cellular response is size-dependent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Size-dependent cellular uptake and expulsion of single-walled carbon nanotubes: single particle tracking and a generic uptake model for nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Vascular targeted therapy with anti-prostate-specific membrane antigen monoclonal antibody J591 in advanced solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Strategies in the design of nanoparticles for therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

The effects of particle size and molecular targeting on the intratumoral and subcellular distribution of polymeric nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Synthesis and in vitro evaluation of cyclic NGR peptide targeted thermally sensitive liposome

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Synergistic antitumor activity of cisplatin, paclitaxel, and gemcitabine with tumor vasculature-targeted tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Targeted drug delivery and penetration into solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Endocytosis of nanomedicines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Effect of surface properties on nanoparticle-cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Cytosolic delivery of membrane-impermeable molecules in dendritic cells using pH-responsive core-shell nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Using nuclear targeting signals to enhance non-viral gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Nuclear pore complex is able to transport macromolecules with diameters of about 39 nm

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

New functions for the matrix metalloproteinases in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

PEGylated PAMAM dendrimer-doxorubicin conjugates: in vitro evaluation and in vivo tumor accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Characterisation and tumour targeting of PEGylated polylysine dendrimers bearing doxorubicin via a pH labile linker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Anti-tumor drug delivery of pH-sensitive poly(ethylene glycol)-poly(L-histidine-)-poly(L-lactide) nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(beta-amino ester) block copolymer micelles for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Development of MRI/NIRF 'activatable' multimodal imaging probe based on iron oxide nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Utilizing cell-matrix interactions to modulate gene transfer to stem cells inside hyaluronic acid hydrogels

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Multistage nanoparticle delivery system for deep penetration into tumor tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

In vitro and in vivo characterization of doxorubicin and vincristine coencapsulated within liposomes through use of transition metal ion complexation and pH gradient loading

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Schedule- and dose-dependency of CPX-351, a synergistic fixed ratio cytarabine:daunorubicin formulation, in consolidation treatment against human leukemia xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Synergistic induction of apoptosis in brain cancer cells by targeted codelivery of siRNA and anticancer drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Cationic drug-derived nanoparticles for multifunctional delivery of anticancer siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Gene and doxorubicin co-delivery system for targeting therapy of glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Dual docetaxel/superparamagnetic iron oxide loaded nanoparticles for both targeting magnetic resonance imaging and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Surface engineering of iron oxide nanoparticles for targeted cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Multifunctional nanoassemblies for vincristine sulfate delivery to overcome multidrug resistance by escaping P-glycoprotein mediated efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Development of novel self-assembled DS-PLGA hybrid nanoparticles for improving oral bioavailability of vincristine sulfate by P-gp inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Amphiphilic polysaccharide-hydrophobicized graft polymeric micelles for drug delivery nanosystems

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

A novel stealth liposomal topotecan with amlodipine: apoptotic effect is associated with deletion of intracellular Ca2+ by amlodipine thus leading to an enhanced antitumor activity in leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Modulation of drug resistance in ovarian adenocarcinoma by enhancing intracellular ceramide using tamoxifen-loaded biodegradable polymeric nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Minicells: versatile vectors for targeted drug or si/shRNA cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Cooperative nanomaterial system to sensitize, target, and treat tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Implications of tumor progression on clinical oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Dual-targeting of αvβ3 and galectin-1 improves the specificity of paramagnetic/fluorescent liposomes to tumor endothelium in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Efficient delivery of gold nanoparticles by dual receptor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Anti-tumor activity of paclitaxel through dual-targeting carrier of cyclic RGD and transferrin conjugated hyperbranched copolymer nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Dual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Multi-core vesicle nanoparticles based on vesicle fusion for delivery of chemotherapic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Biodegradable nanocomposite microparticles as drug delivering injectable cell scaffolds

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Multistage nanovectors: from concept to novel imaging contrast agents and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Porous nanoparticle supported lipid bilayers (protocells) as delivery vehicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Silica nanoparticle supported lipid bilayers for gene delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Formation of supported bilayers on silica substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

The formation of supported lipid bilayers on silica nanoparticles revealed by cryoelectron microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

Systemic delivery of siRNA to tumors using a lipid nanoparticle containing a tumor-specific cleavable PEG-lipid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

A tumor-environment-responsive nanocarrier that evolves its surface properties upon sensing matrix metalloproteinase-2 and initiates agglomeration to enhance T₂ relaxivity for magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2NR32867D

21 January 2018

Identifiers

DOI

10.1039/C2NR32867D

1 reference

release_ecdw5xxipzgs7ix477yn3svhpm

28 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ecdw5xxipzgs7ix477yn3svhpm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference